Is it safe?
Can BIO take a bad year?
Bio-Rad Laboratories, Inc. holds $762M more cash than debt, so a bad year is a question about profits, not about lenders.
$762M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 3.15
Altman Z-score · safe zone, above 3
- Interest cover
- 1.17×
Interest cover · operating profit barely covers the interest bill
Details›
- Total debtQ1 2026
- $803M
- Cash and short-term investments
- $1.56B
- Net cash
- $762M
- Operating profit, trailing twelve months
- $58M
- Debt / equity
- 0.12×
- Annualised volatilitytwo years of daily moves
- 41%
- Worst drawdown on file
- −74%
- Below its 52-week high
- −0.31%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Devices
Ranks #27 of 35 by Smart Score